Leukotriene B4 receptor BLT2 negatively regulates allergic airway eosinophilia

Yuko Matsunaga, Satoru Fukuyama, Toshiaki Okuno, Fumiyuki Sasaki, Takehiko Matsunobu, Yukari Asai, Koichiro Matsumoto, Kazuko Saeki, Masahiro Oike, Yukari Sadamura, Kentaro Machida, Yoichi Nakanishi, Masato Kubo, Takehiko Yokomizo, Hiromasa Inoue

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Leukotriene B4 (LTB4) has been implicated in the pathogenesis of allergic diseases. BLT2, a low-affinity LTB4 receptor, is activated by LTB4 and 12(S)-hydroxyheptadeca-5Z,8E,10E-trienoic acid (12-HHT). Although the high-affinity LTB4 receptor BLT1 has been shown to exert proinflammatory roles, the role of BLT2 in allergic inflammation has not been clarified. To study the function of BLT2 in development of asthma, we used mice model of ovalbumin (OVA)-induced allergic airway disease. The 12-HHT levels were elevated in bronchoalveolar lavage (BAL) fluids of OVA-sensitized/challenged wild-type mice. BLT2-deficient mice exhibited enhanced eosinophilia in BAL fluids after OVA exposure. Interleukin (IL)-13 levels in BAL fluids and IL-13-producing CD 4+ T cells in the lungs were elevated in BLT2-deficient mice compared to wild-type mice, whereas the levels of IL-4, IL-5, and interferon (IFN) in BAL fluids and serum OVA-specific IgE were comparable. Transfection of BLT2-specific small interfering RNA enhanced IL-13 production in CD4+ T cells in vitro. Expression of BLT2 mRNA in CD4+ T cells was significantly reduced in patients with asthma compared to healthy control subjects. These findings indicate that BLT2 has a protective role in allergic airway inflammation and that diminished BLT2 expression in CD4+ T cells may contribute to the pathophysiology of asthma.

Original languageEnglish
Pages (from-to)3306-3314
Number of pages9
JournalFASEB Journal
Volume27
Issue number8
DOIs
Publication statusPublished - Aug 1 2013

Fingerprint

Leukotriene B4 Receptors
T-cells
Ovalbumin
Eosinophilia
Interleukin-13
Bronchoalveolar Lavage Fluid
Leukotriene B4
Fluids
T-Lymphocytes
Asthma
Interleukin-5
Inflammation
Interleukin-4
Interferons
Immunoglobulin E
Small Interfering RNA
Transfection
Healthy Volunteers
Messenger RNA
Acids

All Science Journal Classification (ASJC) codes

  • Biotechnology
  • Biochemistry
  • Molecular Biology
  • Genetics

Cite this

Matsunaga, Y., Fukuyama, S., Okuno, T., Sasaki, F., Matsunobu, T., Asai, Y., ... Inoue, H. (2013). Leukotriene B4 receptor BLT2 negatively regulates allergic airway eosinophilia. FASEB Journal, 27(8), 3306-3314. https://doi.org/10.1096/fj.12-217000

Leukotriene B4 receptor BLT2 negatively regulates allergic airway eosinophilia. / Matsunaga, Yuko; Fukuyama, Satoru; Okuno, Toshiaki; Sasaki, Fumiyuki; Matsunobu, Takehiko; Asai, Yukari; Matsumoto, Koichiro; Saeki, Kazuko; Oike, Masahiro; Sadamura, Yukari; Machida, Kentaro; Nakanishi, Yoichi; Kubo, Masato; Yokomizo, Takehiko; Inoue, Hiromasa.

In: FASEB Journal, Vol. 27, No. 8, 01.08.2013, p. 3306-3314.

Research output: Contribution to journalArticle

Matsunaga, Y, Fukuyama, S, Okuno, T, Sasaki, F, Matsunobu, T, Asai, Y, Matsumoto, K, Saeki, K, Oike, M, Sadamura, Y, Machida, K, Nakanishi, Y, Kubo, M, Yokomizo, T & Inoue, H 2013, 'Leukotriene B4 receptor BLT2 negatively regulates allergic airway eosinophilia', FASEB Journal, vol. 27, no. 8, pp. 3306-3314. https://doi.org/10.1096/fj.12-217000
Matsunaga, Yuko ; Fukuyama, Satoru ; Okuno, Toshiaki ; Sasaki, Fumiyuki ; Matsunobu, Takehiko ; Asai, Yukari ; Matsumoto, Koichiro ; Saeki, Kazuko ; Oike, Masahiro ; Sadamura, Yukari ; Machida, Kentaro ; Nakanishi, Yoichi ; Kubo, Masato ; Yokomizo, Takehiko ; Inoue, Hiromasa. / Leukotriene B4 receptor BLT2 negatively regulates allergic airway eosinophilia. In: FASEB Journal. 2013 ; Vol. 27, No. 8. pp. 3306-3314.
@article{8dac374202d5421484dfaa4a698e770a,
title = "Leukotriene B4 receptor BLT2 negatively regulates allergic airway eosinophilia",
abstract = "Leukotriene B4 (LTB4) has been implicated in the pathogenesis of allergic diseases. BLT2, a low-affinity LTB4 receptor, is activated by LTB4 and 12(S)-hydroxyheptadeca-5Z,8E,10E-trienoic acid (12-HHT). Although the high-affinity LTB4 receptor BLT1 has been shown to exert proinflammatory roles, the role of BLT2 in allergic inflammation has not been clarified. To study the function of BLT2 in development of asthma, we used mice model of ovalbumin (OVA)-induced allergic airway disease. The 12-HHT levels were elevated in bronchoalveolar lavage (BAL) fluids of OVA-sensitized/challenged wild-type mice. BLT2-deficient mice exhibited enhanced eosinophilia in BAL fluids after OVA exposure. Interleukin (IL)-13 levels in BAL fluids and IL-13-producing CD 4+ T cells in the lungs were elevated in BLT2-deficient mice compared to wild-type mice, whereas the levels of IL-4, IL-5, and interferon (IFN) in BAL fluids and serum OVA-specific IgE were comparable. Transfection of BLT2-specific small interfering RNA enhanced IL-13 production in CD4+ T cells in vitro. Expression of BLT2 mRNA in CD4+ T cells was significantly reduced in patients with asthma compared to healthy control subjects. These findings indicate that BLT2 has a protective role in allergic airway inflammation and that diminished BLT2 expression in CD4+ T cells may contribute to the pathophysiology of asthma.",
author = "Yuko Matsunaga and Satoru Fukuyama and Toshiaki Okuno and Fumiyuki Sasaki and Takehiko Matsunobu and Yukari Asai and Koichiro Matsumoto and Kazuko Saeki and Masahiro Oike and Yukari Sadamura and Kentaro Machida and Yoichi Nakanishi and Masato Kubo and Takehiko Yokomizo and Hiromasa Inoue",
year = "2013",
month = "8",
day = "1",
doi = "10.1096/fj.12-217000",
language = "English",
volume = "27",
pages = "3306--3314",
journal = "FASEB Journal",
issn = "0892-6638",
publisher = "FASEB",
number = "8",

}

TY - JOUR

T1 - Leukotriene B4 receptor BLT2 negatively regulates allergic airway eosinophilia

AU - Matsunaga, Yuko

AU - Fukuyama, Satoru

AU - Okuno, Toshiaki

AU - Sasaki, Fumiyuki

AU - Matsunobu, Takehiko

AU - Asai, Yukari

AU - Matsumoto, Koichiro

AU - Saeki, Kazuko

AU - Oike, Masahiro

AU - Sadamura, Yukari

AU - Machida, Kentaro

AU - Nakanishi, Yoichi

AU - Kubo, Masato

AU - Yokomizo, Takehiko

AU - Inoue, Hiromasa

PY - 2013/8/1

Y1 - 2013/8/1

N2 - Leukotriene B4 (LTB4) has been implicated in the pathogenesis of allergic diseases. BLT2, a low-affinity LTB4 receptor, is activated by LTB4 and 12(S)-hydroxyheptadeca-5Z,8E,10E-trienoic acid (12-HHT). Although the high-affinity LTB4 receptor BLT1 has been shown to exert proinflammatory roles, the role of BLT2 in allergic inflammation has not been clarified. To study the function of BLT2 in development of asthma, we used mice model of ovalbumin (OVA)-induced allergic airway disease. The 12-HHT levels were elevated in bronchoalveolar lavage (BAL) fluids of OVA-sensitized/challenged wild-type mice. BLT2-deficient mice exhibited enhanced eosinophilia in BAL fluids after OVA exposure. Interleukin (IL)-13 levels in BAL fluids and IL-13-producing CD 4+ T cells in the lungs were elevated in BLT2-deficient mice compared to wild-type mice, whereas the levels of IL-4, IL-5, and interferon (IFN) in BAL fluids and serum OVA-specific IgE were comparable. Transfection of BLT2-specific small interfering RNA enhanced IL-13 production in CD4+ T cells in vitro. Expression of BLT2 mRNA in CD4+ T cells was significantly reduced in patients with asthma compared to healthy control subjects. These findings indicate that BLT2 has a protective role in allergic airway inflammation and that diminished BLT2 expression in CD4+ T cells may contribute to the pathophysiology of asthma.

AB - Leukotriene B4 (LTB4) has been implicated in the pathogenesis of allergic diseases. BLT2, a low-affinity LTB4 receptor, is activated by LTB4 and 12(S)-hydroxyheptadeca-5Z,8E,10E-trienoic acid (12-HHT). Although the high-affinity LTB4 receptor BLT1 has been shown to exert proinflammatory roles, the role of BLT2 in allergic inflammation has not been clarified. To study the function of BLT2 in development of asthma, we used mice model of ovalbumin (OVA)-induced allergic airway disease. The 12-HHT levels were elevated in bronchoalveolar lavage (BAL) fluids of OVA-sensitized/challenged wild-type mice. BLT2-deficient mice exhibited enhanced eosinophilia in BAL fluids after OVA exposure. Interleukin (IL)-13 levels in BAL fluids and IL-13-producing CD 4+ T cells in the lungs were elevated in BLT2-deficient mice compared to wild-type mice, whereas the levels of IL-4, IL-5, and interferon (IFN) in BAL fluids and serum OVA-specific IgE were comparable. Transfection of BLT2-specific small interfering RNA enhanced IL-13 production in CD4+ T cells in vitro. Expression of BLT2 mRNA in CD4+ T cells was significantly reduced in patients with asthma compared to healthy control subjects. These findings indicate that BLT2 has a protective role in allergic airway inflammation and that diminished BLT2 expression in CD4+ T cells may contribute to the pathophysiology of asthma.

UR - http://www.scopus.com/inward/record.url?scp=84881160011&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84881160011&partnerID=8YFLogxK

U2 - 10.1096/fj.12-217000

DO - 10.1096/fj.12-217000

M3 - Article

C2 - 23603839

AN - SCOPUS:84881160011

VL - 27

SP - 3306

EP - 3314

JO - FASEB Journal

JF - FASEB Journal

SN - 0892-6638

IS - 8

ER -